Potential Role of Elacestrant for the Treatment of Metastatic ER+/HER2- Breast Cancer

home / investigator-perspectives / potential-role-of-elacestrant-for-the-treatment-of-metastatic-er-her2-breast-cancer

Dr Aditya Bardia reviews the potential role of elacestrant for the treatment of metastatic ER+/HER2- breast cancer, starting with an overview of the current landscape and focusing specifically on key efficacy data from the EMERALD Trial.